Duncan Technology Group Completes Reverse Merger with Ascentia Biomedical Corporation

NEW YORK, N.Y. – Dec. 7 (SEND2PRESS NEWSWIRE) — Ascentia Biomedical Corporation (‘Ascentia’) (OTC: ASCE / ASCE.pk) today announced that, effective November 28, 2006, it has completed the acquisition of all the outstanding common stock of Fortress Technology Systems, Inc. (‘Fortress’), pursuant to a share exchange agreement. Ascentia acquired all of the outstanding shares of Fortress common and preferred stock in exchange for 254,531,004 shares of Ascentia common stock and 8,000,000 shares of Ascentia Series A Preferred Stock.